Disclaimer

Adipose derived mesenchymal stem cell (AD-MSC) therapy has been exhibited to improve the state of Ataxia. In this study, low-dose IV infusion of AD-MSCs is addressed as it might have a progressively long-lasting effect on the repressed cerebral/cerebellar glucose metabolism leading to stabilization of the disease. 

Hereditary ataxia can be improved through a combination of umbilical cord mononuclear cell (UCMB) transplantation and rehabilitation training on equilibrium function. Along with the immune markers showing a statistically significant endpoint, the symptomatic measures were also found to improve persistently among the subjects. 

A potential solution for not one but TWO conditions! 🤩 A clinical analysis on umbilical cord mesenchymal stromal cells as a treatment for spinocerebellar ataxia and multiple system atrophy-cerebellar type. The results show a significant improvement in the scores of both ICARS and ADL scales post-treatment.  

The magic of mesenchymal stem cells (MSCs)🔮✨! Ataxia can be improved via intrathecal injection of allogeneic bone marrow derived-MSCs. The neuroprotective effect induced through this treatment has contributed to the improvement of Ataxia within the period of 10 months 📈.